IMF’s Nurse Leadership Board Authors ‘Multiple Myeloma’ Supplement in CJON Read more about IMF’s Nurse Leadership Board Authors ‘Multiple Myeloma’ Supplement in CJONAdd new comment
Two New Clinical Trials are Accruing Patients for Studies of the Role of Selinexor in Myeloma Read more about Two New Clinical Trials are Accruing Patients for Studies of the Role of Selinexor in MyelomaAdd new comment
Further FDA clinical trial holds may signal the end for checkpoint inhibitors in myeloma Week in Review
Report from the 2017 Summit of the International Myeloma Working Group Read more about Report from the 2017 Summit of the International Myeloma Working Group Add new comment
University of California girds to combat cancer, a closer look at CAR-T cell therapy, and medical tourism to China—a wave of the future? Week in Review
Closing or Halting of Myeloma Immune Therapy Trials: A Major Setback for Patients and Drug Companies Week in Review
FDA Statement regarding safety concerns related to investigational use of Keytruda in multiple myeloma Read more about FDA Statement regarding safety concerns related to investigational use of Keytruda in multiple myelomaAdd new comment
